 Company to Present Corporate Update During Investor Webcast, May 24, 2022, at 7:00am ET RADNOR, Pa. , May 19, 2022 PRNewswire -- NRx Pharmaceuticals, Inc. Nasdaq: NRXP, a clinical-stage biopharmaceutical company, today announced its interim Chief Executive Officer, Robert Besthof, and other executive leaders will be presenting a virtual update to the companys business via webcast at the H.C. 